General Information of the Compound
| Compound ID |
CP0191326
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[1-[[(3S,4R)-1-(cyclopentanecarbonyl)-4-hydroxy-4-phenylpyrrolidin-3-yl]methyl]piperidin-4-yl]-2-[4-(methylsulfamoyl)phenyl]-N-prop-2-enylacetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H46N4O5S
|
||||||||||||||||||
| Molecular Weight |
622.832
|
||||||||||||||||||
| Canonical SMILES |
CNS(=O)(=O)c1ccc(CC(=O)N(CC=C)C2CCN(C[C@H]3CN(C[C@]3(O)c3ccccc3)C(=O)C3CCCC3)CC2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C34H46N4O5S/c1-3-19-38(32(39)22-26-13-15-31(16-14-26)44(42,43)35-2)30-17-20-36(21-18-30)23-29-24-37(33(40)27-9-7-8-10-27)25-34(29,41)28-11-5-4-6-12-28/h3-6,11-16,27,29-30,35,41H,1,7-10,17-25H2,2H3/t29-,34-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
XPFKJEFRGMJTEE-DODOAAEWSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound